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Strains of Enterococcus faecium express a cell wall-anchored protein, Acm, which mediates adherence to
collagen. Here, we (i) identify the minimal and high-affinity binding subsegments of Acm and (ii) show that
anti-Acm immunoglobulin Gs (IgGs) purified against these subsegments reduced E. faecium TX2535 strain
collagen adherence up to 73 and 50%, respectively, significantly more than the total IgGs against the full-length
Acm A domain (28%) (P < 0.0001). Blocking Acm adherence with functional subsegment-specific antibodies
raises the possibility of their use as therapeutic or prophylactic agents.
Enterococcus faecium, a gram-positive commensal inhabiting
normal human gut, has been recognized as an opportunistic
pathogen capable of causing life-threatening infections, includ-
ing infective endocarditis (3). The ability of E. faecium to
colonize vascular tissue is believed to occur by MSCRAMM
(7) interactions with ligand at the sites of endovascular injuries.
We have recently reported that some clinically derived E. fae-
cium strains can adhere to collagen and identified a gene
named acm encoding an adhesin of collagen from E. faecium
(6). Acm has characteristics typical of an MSCRAMM (7) with
an N-terminal signal peptide, followed by a nonrepeated A
domain, various numbers of B repeats depending on the strain,
and C-terminal motifs required for surface sorting and cova-
lent anchoring to peptidoglycan (Fig. 1A).
Characterization of acm from diverse strains identified the
predominance of a functional acm gene in clinically derived
isolates versus a pseudogene in many fecal (6) and animal
(S. R. Nallapareddy and B. E. Murray, unpublished results)
isolates. Genetic analysis confirmed that Acm is necessary to
mediate the attachment of E. faecium strains to collagen (5).
Our previous study localized the collagen type I binding
activity of Acm to the 501-amino-acid (aa) A domain (6). The
Acm A domain shares considerable sequence homology with a
family of structurally related collagen-binding adhesins found
in five gram-positive pathogens, namely, Staphylococcus aureus
(8), Enterococcus faecalis (4), Streptococcus equi (2), Erysipelo-
thrix rhusiopathiae (12), and Streptococcus mutans (11). Cna of
S. aureus, the prototype member of this family, has been ex-
tensively characterized at the structural level (8, 10, 15, 17).
The ligand-binding A domain of Cna contains three subdo-
mains, named N1, N2, and N3, each adopting an immunoglob-
ulin (Ig)-like fold (9). It was recently shown that the protein
construct corresponding to the N1N2 subdomains bound col-
lagen with an affinity higher than that of the full-length A
domain (17). Based on crystal structures of Cna N1N2 as an
apoprotein and in complex with a synthetic collagen-like pep-
tide, a multistep “Collagen Hug” binding model was proposed
for the binding of Cna to collagen triple helices (17).
Subdomain organization of Acm A domain. By comparing
the amino acid sequences of Acm and Cna, and guided by
molecular modeling, we found that the A domain of Acm also
appears to be composed of three subdomains: N1, correspond-
ing to aa 29 to 150, N2, corresponding to aa 151 to 346, and N3,
corresponding to aa 347 to 529 (Fig. 1A); the previously pre-
dicted minimal region of Acm required for collagen binding
(aa 151 to 320) would correspond to a truncated form of the
N2 domain (6). Molecular modeling suggests that these
domains could adopt the previously identified DE variant of
the Ig fold (Fig. 1B), characteristic of staphylococcal
MSCRAMMs (1). The predicted N1N2 region of Acm is al-
most the same size (318 aa) as the N1N2 region of Cna (314
aa), and they exhibit 46% identity and 56% similarity (6, 10,
17). In addition, the C-terminal latch region of the N2 domain
(ASGGVNG), which is predicted to interact with the N1 do-
main to complement one of the -sheets of the N1 domain in
a proposed cleft formed by VEGWGQF (VSGFAEF in Cna)
for securing the MSCRAMM-collagen complex, is conserved
(Fig. 1B) (17). In the current work, we expressed six different
recombinant proteins of Acm subregions, characterized their
binding to collagen, and tested for alteration of adherence of
E. faecium to collagen with subregion-specific antibodies.
Recombinant constructs. The following recombinant con-
structs were made: (i) truncated N2, lacking the latch region,
corresponding to aa 151 to 320, (ii) N2 (aa 151 to 346), (iii)
combinations of tandem subdomains (i.e., N2N3 [residues 151
to 529], N1N2truncate [aa 29 to 320], and N1N2 [aa 29 to
346]), and (iv) the full-length A domain (N1N2N3 [aa 29 to
529]) (Fig. 1A). DNA fragments were PCR amplified from the
previously generated pTEX5330 encoding the complete Acm
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A domain of the collagen-adhering E. faecium strain TX2555
(6), using primers listed in Table 1, cloned into the pQE30
expression vector as described previously (6, 13), and con-
firmed by DNA sequencing. The expression and large-scale
purification of the recombinant fragments, using a nickel-
charged HiTrap chelating HP column followed by a HiTrap
Q-Sepharose column (Amersham), were as described previ-
ously (6, 13), and this method of using two different columns
allowed for the isolation of essentially pure proteins that were
estimated to be 95% pure. Purified recombinant proteins
were named based on their molecular sizes (Fig. 1 and Table
1). Analysis of these recombinant proteins by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis showed the migra-
tion of all proteins at their predicted molecular sizes (Fig. 1C).
However, a second band of smaller molecular size, likely rep-
resenting degradation, was observed in the preparations of
proteins rAcm21 and rAcm58 upon overnight storage even un-
der different conditions. Verification by mass spectrometry in-
FIG. 1. Recombinant constructs, purified proteins, and predicted model that adopts the previously identified DE variant of the Ig fold.
(A) Schematic representation of the subdomains of E. faecium Acm and different constructs. The collagen-binding A domain is followed by B
repeats. S, signal peptide; W, cell wall-anchoring region containing LPKTS; M, transmembrane segment; C, cytoplasmic tail. The three subdomains
of the A domain are from residues 29 to 150 (N1), 151 to 346 (N2), and 347 to 529 (N3). The previously predicted minimum collagen-binding
domain is from residues 151 to 320 (6, 10, 17). The predicted latch sequence (ASGGVNG) and the corresponding latch cleft region (VEGWGQF)
of the N1 domain are shown. Recombinant proteins are indicated by the subdomain compositions. All constructed recombinant proteins contain
an N-terminal His tag, as illustrated by “–.” (B) Ribbon representation of the model of Acm. A theoretical model of the structure of rAcm37 was
obtained by homology modeling, using the crystal structure of Cna (Protein Data Bank identification no. 2F68) as a template. The HOMOLOGY
module available in InsightII (Accelrys Inc., San Diego, CA) was used to build the model. The N1 and N2 subdomains are shown in light and dark
gray shades, respectively. The five key residues predicted as potential contact points with the collagen in the N2 subdomain are shown as gray stick
objects; these amino acids were shown to be critical for collagen binding by Cna of S. aureus (14). The three pairs of hydrogen bonds that would
stabilize the closed conformation (latching event) of the “Collagen Hug” model (17) are marked as dotted lines. (C) Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis analysis of recombinant His6-Acm constructs after purification. Lanes: 1, molecular mass standards; 2, Acm21;
3, Acm24; 4, Acm44; 5, Acm34; 6, Acm37; 7, Acm58.
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dicated that the bands of rAcm24, rAcm44, rAcm34, and rAcm37
proteins and larger bands of rAcm21 and rAcm58 were of full
size (Table 1).
Identification of minimal and high-affinity binding subseg-
ments of Acm A domain. To test the interaction of each of the
recombinant Acm A-domain subsegments with immobilized
collagen, 20 M concentrations of recombinant proteins were
used in an enzyme-linked immunosorbent assay-type ligand-
binding assay (16). In brief, purified recombinant Acm proteins
were added to microtiter wells coated with 1 g of collagen
type I (Sigma) and the bound recombinant proteins were de-
tected with mouse anti-His monoclonal antibody (Amersham),
followed by alkaline phosphatase-conjugated rabbit anti-
mouse IgG (Bio-Rad).
The full-length A domain (rAcm58) and three subsegments
(rAcm24, N2; rAcm37, N1N2; and rAcm44, N2N3) each bound
to immobilized collagen (Fig. 2A). rAcm37, containing the pre-
dicted N1N2 domains, bound collagen with a substantially
higher apparent affinity than the full-length A domain
(rAcm58) (Fig. 2A). A similar observation was previously re-
ported for Cna (17). Recombinant protein that contained the
complete N2 domain (rAcm24) bound collagen with a lower
affinity but higher than that of rAcm44 (N2N3). Recombinant
proteins representing the previously predicted minimal region
required for collagen binding (rAcm21) and N1N2truncate
(rAcm34) did not show any measurable binding for collagen,
suggesting that the complete N2 domain, including the puta-
tive latch region, is critical for the binding activity of this
protein. Further analyses using 1 to 50 M of Acm proteins
confirmed the relative affinities for rAcm24 and rAcm37 (Fig.
2B). As shown in Fig. 2B, the collagen-coated wells were sat-
urated with rAcm37, but not with rAcm24, at the concentrations
indicated. A concentration-dependent curve for a recombinant
protein similar to rAcm58 (but expressed in pBADHisA vec-
tor) has previously been reported (6).
Taken together, the relative binding abilities of different
TABLE 1. Recombinant constructs used in this study and oligonucleotide primers used to amplify the subsegments of the Acm A domain
Expression
construct Subdomain aa
Molecular mass
(kDa)b
Recombinant
protein Sequence
a
pTEX5411 N2trun 151–320 20.881 rAcm21 5-CGCGGATCCGTGACGAGCGGTGATAAAACAGCTACTG
5-CGGGGTACCTTAATTTTTAACTGTATGATTGAAACTTTC
pTEX5412 N2 151–346 23.667 rAcm24 5-CGCGGATCCGTGACGAGCGGTGATAAAACAGCTACTG
5-CGGGGTACCTTAAATCTCTGTGTCATTGATATATTTG
pTEX5413 N2N3 151–529 44.286 rAcm44 5-CGCGGATCCGTGACGAGCGGTGATAAAACAGCTACTG
5-CGGGGTACCTTATTTATTCTCATTTGTAACGACTAGC
pTEX5414 N1N2trun 29–320 34.401 rAcm34 5-CGCGGATCCGATGCAGGCAGAGATATCAGCAGTAATG
5-CGGGGTACCTTAATTTTTAACTGTATGATTGAAACTTTC
pTEX5415 N1N2 29–346 37.147 rAcm37 5-CGCGGATCCGATGCAGGCAGAGATATCAGCAGTAATG
5-CGGGGTACCTTAAATCTCTGTGTCATTGATATATTTG
pTEX5416 N1N2N3 29–529 57.900 rAcm58 5-CGCGGATCCGATGCAGGCAGAGATATCAGCAGTAATG
5-CGGGGTACCTTATTTATTCTCATTTGTAACGACTAGC
a The introduced restriction sites are underlined, and stop codons are italicized.
b Molecular masses were estimated by matrix-assisted laser desorption ionization–time of flight mass spectrometry.
FIG. 2. Binding characteristics of recombinant Acm A-domain subsegments. (A) Binding of 20 M recombinant Acm A-domain subsegments
to immobilized collagen type I. This experiment was repeated three times using different batches of protein purification. Values represent the
means  standard errors of the means from three independent experiments using different batches of protein purification. The binding of rAcm37
to fibrinogen (additional negative control) is also shown. (B) Binding curves of high-affinity binding subdomains (rAcm37) and the minimal region
required for binding (rAcm24) to 1 g of immobilized collagen as a function of their concentration. Values represent the means  standard
deviations from two independent experiments using the same batch of protein purification. BSA, bovine serum albumin.
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subsegments of Acm are comparable to the binding character-
istics of similar subsegments of Cna, consistent with the hy-
pothesis that Acm N1N2 subdomains may adopt similar two-
domain structures, with N2 being the binding subdomain, and
use the “Collagen Hug” mechanism for binding to collagen
(17). In this model, the C-terminal region of the N2 subdomain
is proposed to overlap with the N1 domain and function as a
latch by complementing one of the -sheets of the N1 domain
for securing the Acm-collagen complex in the closed confir-
mation (Fig. 1B).
Inhibition of E. faecium cells adhering to collagen by re-
combinant Acm A-domain subsegments. We have previously
reported partial reduction in the adherence of the vancomycin-
resistant endocarditis-derived E. faecium isolate TX2535 (6) to
collagen upon preincubation of collagen-coated wells with the
recombinant full-length Acm A domain but only at concentra-
tions greater than that for the saturated binding of the recom-
binant Acm A domain. In this study, two different recombinant
Acm subsegments (rAcm37 and rAcm24) that exhibit different
collagen-binding affinities were examined for their abilities to
inhibit the adherence of TX2535 to collagen. For inhibition
experiments, collagen-coated wells were incubated with vari-
ous concentrations (5 to 60 M) of recombinant proteins for
2 h at 37°C. The wells were then washed in phosphate-buffered
saline containing 0.1% Tween 80 and 0.1% bovine serum al-
bumin to remove excess unbound proteins prior to the addition
of labeled cells in a previously described adherence assay (6).
Both of the recombinant proteins partially inhibited bacterial
attachment at concentrations higher than 40 M. At a 60 M
concentration, the collagen adherence reduction percentages
for rAcm37, rAcm58, and rAcm24 were 55, 43, and 15%, respec-
tively (data not shown). Thus, the differences seen between the
subsegment constructs in their binding to collagen are re-
flected by a difference in their ability to inhibit Acm-dependent
bacterial attachment to collagen. The observed partial inhibi-
tory effect suggests that native Acm may have a higher affinity
to immobilized collagen than recombinant subsegments.
Concentration-dependent inhibition of collagen adherence
of two endocarditis-derived E. faecium isolates with specific
antibodies against collagen-binding subsegments. For inhibi-
tion studies, three sets of anti-Acm polyclonal IgGs were used:
(i) total IgGs from rabbit antisera raised against the Acm A
domain (6) purified by affinity chromatography on a protein G
column (Pierce), (ii) specific IgGs eluted against the high-
affinity binding segment, rAcm37, and (iii) specific IgGs eluted
against the minimal region required for collagen binding,
rAcm24. The last two specific IgGs were prepared using the
respective recombinant proteins (coupled to cyanogen bro-
mide-activated Sepharose 4B) as immunoabsorbents according
to the manufacturer’s protocol (Amersham). Of note, deter-
mination of the titers of total anti-Acm IgGs in an enzyme-
linked immunosorbent assay showed that anti-Acm IgGs
saturate 1 g/ml recombinant Acm58 when added at a concen-
tration of 3 g/ml or higher (data not shown).
For inhibition by IgGs, labeled bacteria were preincubated
with 10-g/ml concentrations of the three anti-Acm IgGs men-
tioned above for 1 h at 37°C, and 50 l of these cells was then
added to the collagen- or fibrinogen-coated wells in the adher-
ence assay described earlier (6). The cells used in this assay
were grown to entry into stationary phase, the phase at which
we detected Acm on the surface of 93% of cells of TX2535
by using flow cytometry (S. R. Nallapareddy et al., unpublished
data). IgGs from preimmune rabbit serum served as a control.
All of the data presented are means  standard deviations of
the results of three to four independent experiments. Statisti-
cal analysis was done by analysis of variance with Bonferroni’s
post hoc modification for multiple comparisons.
As shown in Fig. 3A, all three anti-Acm IgGs inhibited the
FIG. 3. Inhibition of E. faecium strain TX2535 adherence to collagen by anti-Acm IgGs affinity purified against different segments of the Acm
A domain. (A) Inhibition of adherence by 10 g/ml of anti-rAcm A-domain total IgGs, specific anti-rAcm37 IgGs, and specific anti-rAcm24 IgGs.
The adherence of TX2535 to bovine serum albumin (BSA) is also shown. Bars represent the means of the percentages of adhering cells standard
deviations for six wells. Results are from three independent experiments. Anti-Acm antibodies did not inhibit the adherence of TX2535 to
fibrinogen (data not shown). (B) Dose-dependent effects of anti-Acm IgGs. Data points were normalized with the respective data points for
bacteria adhering in the absence of IgGs and expressed as percentages. Data points represent the means standard deviations for six wells (results
are from three independent experiments, with two wells per experiment).
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adherence of TX2535 to collagen. However, the reduction in
adherence seen with binding region-specific (anti-rAcm37 and
anti-rAcm24) IgGs was considerably greater than that seen
with total anti-rAcmA IgGs: 73.4%, 50.2%, and 27.9% reduc-
tion with anti-rAcm37 IgGs, anti-rAcm24 IgGs, and anti-Acm
total IgGs, respectively, compared to 2.7% reduction with pre-
immune IgGs (P  0.0001 and P  0.001, respectively, for
multiple comparisons). In addition, the reduction differences
between anti-rAcm37 IgGs, anti-rAcm24 IgGs, and anti-Acm
total IgGs were also statistically significant (P  0.001 for
anti-rAcm37 versus the other two and P 0.05 for anti-rAcm24
IgGs versus anti-Acm total IgGs). As anticipated, anti-Acm
antibodies did not inhibit the adherence of this strain to fibrin-
ogen (data not shown). We have also tested the effects of these
IgGs on the adherence of another endocarditis-derived E. fae-
cium isolate, TX0082. The collagen reduction percentages af-
ter preincubation with anti-Acm IgGs for TX0082 were 80.0%,
49.5%, and 31.9% for anti-rAcm37 IgGs, anti-rAcm24 IgGs,
and anti-Acm total IgGs, respectively, compared to a 10.6%
increase for preimmune IgGs (P  0.0001) (data not shown).
In subsequent inhibition experiments, we tested a range of
concentrations (0.05 to 50 g per ml) of each of these IgGs by
using strains TX2535 and TX0082. The results for TX2535
showed that as little as 1 g of specific anti-rAcm37 IgGs per ml
was sufficient to inhibit 39.4% of the adherence to collagen,
whereas preimmune serum had no effect on adherence over
the range of concentrations tested (Fig. 3B). Furthermore, the
inhibition effect was concentration dependent (Fig. 3B).
The results for TX0082 also indicate that anti-rAcm37 IgGs
were the most effective in inhibiting cell adhesion, causing 80%
inhibition of cell adhesion at 20 g/ml (data not shown). Anti-
Acm A-domain total IgGs also caused some reduction in ad-
herence but were less potent than anti-rAcm24; the reduction
differences were consistent over the concentrations tested
(data not shown).
The finding that anti-Acm antibodies are able to reduce the
adherence of E. faecium to collagen raises the possibility that
these antibodies may have potential as therapeutic or prophy-
lactic agents. Our ongoing studies using a rat endocarditis
model may provide some evidence in this direction.
In summary, the biochemical analysis of recombinant sub-
domains of Acm showing that the high-affinity binding subseg-
ment contains two Ig-like similarly folded (based on structural
predictions) subdomains supports the hypothesis that Acm
may mediate adhesion via the proposed “Collagen Hug” mech-
anism (17). Definitive proof of this hypothesis needs to be
derived from biophysical and structural analyses of these re-
combinant proteins. We also found that specific antibodies
against high-affinity binding subsegments were the most effec-
tive at inhibiting E. faecium adherence to collagen. Thus,
blocking Acm with functional subsegment-specific antibodies
could potentially reduce E. faecium colonization of collagen-
enriched host endovascular tissues.
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